SCHEMBL3268524

SCHEMBL3268524

CC(C)(C)OC(=O)N1CCN(c2cccc(-c3cccc(F)c3F)n2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 2/20 0.48
SKP1 P63208 2/20 0.48
SKP2 Q13309 2/20 0.48
MAP4K4 O95819 1/20 0.47
CXCR2 P25025 1/20 0.47
SMARCA2 P51531 1/20 0.46
SMARCA4 P51532 1/20 0.46
PBRM1 Q86U86 1/20 0.46
GPR119 Q8TDV5 5/20 0.45
SUV39H2 Q9H5I1 2/20 0.44
FAAH O00519 2/20 0.43
PDK2 Q15119 1/20 0.43
KIF18A Q8NI77 1/20 0.43
TP53 P04637 1/20 0.42
THRB P10828 1/20 0.42
PRMT5 O14744 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3268450 0.85 FAAH (0.60) CKS1BSKP1SKP2MAP4K4SMARCA2
SCHEMBL3269283 0.84 CKS1B (0.48) CKS1BSKP1SKP2MAP4K4CXCR2
SCHEMBL3775088 0.84 MAPT (0.50) CKS1BSKP1SKP2CXCR2SMARCA2
SCHEMBL3268523 0.84 SMARCA2 (0.48) CKS1BSKP1SKP2MAP4K4CXCR2
SCHEMBL3268387 0.82 LRRK2 (0.50) CKS1BSKP1SKP2MAP4K4CXCR2
SCHEMBL461584 0.82 CKS1B (0.62) CKS1BSKP1SKP2MAP4K4SMARCA2
SCHEMBL15047026 0.81 CKS1B (0.56) CKS1BSKP1SKP2MAP4K4SMARCA2
SCHEMBL3275117 0.81 CKS1B (0.65) CKS1BSKP1SKP2MAP4K4SMARCA2
SCHEMBL12957576 0.79 TP53 (0.51) CKS1BSKP1SKP2CXCR2SMARCA2
SCHEMBL4690150 0.78 CKS1B (0.48) CKS1BSKP1SKP2MAP4K4GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100234389-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-16 US disclosed
EP-2199282-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2010-06-23 EP disclosed
US-20090163508-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234389-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA CKS1B 3175/4885SKP1 3469/4885SKP2 3535/4885
US-20090163508-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA CKS1B 3175/4885SKP1 3469/4885SKP2 3535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.